Related by context. All words. (Click for frequent words.) 65 Adjuvant Chemotherapy 64 Tumor Response 63 Newly Diagnosed Multiple Myeloma 63 Androgen Deprivation Therapy 63 Improves Outcomes 63 Chemoradiation 63 Hepatitis C Genotype 62 Prolongs Survival 62 Combination Treatment 62 Metastatic Colorectal Cancer 62 Chronic Renal Failure 62 Renal Function 61 Treatment Regimen 61 Partial Onset Seizures 61 Treating Chronic 61 Bipolar Mania 61 Prospective Randomized 61 Patients Receiving 61 Hospital Acquired Pneumonia 61 Is Well Tolerated 61 Decompensated Heart Failure 61 Elderly Patients 61 Renal Impairment 61 Depressive Symptoms 61 Reduces Mortality 61 Progenitor Cells 61 Chemotherapeutic Agents 61 Multiple Myeloma Patients 61 Rheumatoid Arthritis Patients 61 Monotherapy 61 relapsed MM 60 Appears Safe 60 Regimens 60 Adjunctive Therapy 60 Schizophrenia Treatment 60 Long Term Efficacy 60 Pegylated Liposomal Doxorubicin 60 lenalidomide Revlimid R 60 Pneumococcal Vaccine 60 Metastatic Prostate Cancer 60 Percutaneous Coronary Interventions 60 achieved CCyR 60 Unstable Angina 60 Survival Benefit 60 Fludarabine 60 Estrogen Alone 60 Treatment Experienced 60 Castration Resistant Prostate Cancer 60 Investigational Treatment 60 Adjuvant Therapy 60 Improves Survival 60 Cardiotoxicity 60 Combo Therapy 60 Patients Undergoing 60 Protease Inhibitor 59 Antiretroviral Therapy 59 Relapsing Multiple Sclerosis 59 Atypical Antipsychotic 59 Secondary Hyperparathyroidism 59 Improve Survival 59 Protease Inhibitors 59 Treatment Reduces 59 ritonavir boosted 59 alfa 2a 59 Advanced Prostate Cancer 59 Inhaled Nitric Oxide 59 Partial Seizures 59 Allogeneic 59 Osteoarthritis Patients 59 Immune Responses 59 Diabetic Patients 59 Viral Load 59 Patients Treated With 59 Phase 2b Study 59 Follicular Lymphoma 59 Subgroup Analysis 59 Statistically Significant 59 CAELYX 59 Clinical Trial Data 59 Coronary Angiography 59 Diffuse Large B 59 Critically Ill Patients 59 Disease Progression 59 Cell Lymphoma CTCL 59 Hormone Receptor Positive 59 HCV Protease Inhibitor 58 Adverse Effects 58 Postmenopausal Osteoporosis 58 Hepatitis C Virus Infection 58 Infected Patients 58 Renal Insufficiency 58 Diabetic Foot Ulcer 58 Hormone Refractory Prostate Cancer 58 See CLINICAL PHARMACOLOGY 58 Platinol ® 58 Clinical Outcome 58 intradermal injections 58 Complicated Skin 58 DAPT 58 Hydroxyurea 58 Zoledronic Acid 58 docetaxel Taxotere ® 58 Adjunctive 58 Diagnostic Criteria 58 Phase 2b Clinical Trial 58 Diabetic Neuropathy 58 Pharmacokinetics PK 58 Etanercept 58 icatibant 58 Percutaneous Tibial Nerve Stimulation 58 Soft Tissue Sarcoma 58 Peritoneal Dialysis 58 Pharmacologic 58 Demonstrates Potent 58 Long Term Outcomes 58 Fondaparinux 58 Progressive Multifocal Leukoencephalopathy 58 methotrexate therapy 58 Kidney Transplants 58 Plaque Psoriasis 58 Severe Asthma 58 Overactive Bladder 58 methotrexate monotherapy 58 Septic Shock 58 Refractory Angina 58 Pegylated Interferon 58 Well Tolerated 58 Cardiac Resynchronization 58 Clinical Trial Evaluating 58 Knee Osteoarthritis 58 Postoperative Pain 57 FDA Approvals 57 Venous Thromboembolism 57 Prophylaxis 57 Immunomodulatory 57 Myelodysplastic Syndromes 57 Accelerated Partial Breast Irradiation 57 BEXXAR Therapeutic Regimen 57 Hypercholesterolemia 57 Anti Tumor Activity 57 HCV Genotype 57 Previously Treated 57 Malignant Glioma 57 Cytarabine 57 Tigecycline 57 dosage regimens 57 Hypertensive Patients 57 Chemotherapy Improves 57 Intravenous Formulation 57 Cutaneous T 57 Systemic Sclerosis 57 Treated Patients 57 Resistant Hypertension 57 Clinical Efficacy 57 Shows Efficacy 57 Fast Track Status 57 ST Segment Elevation 57 Darunavir 57 Pediatric Patients 57 Non Responders 57 Tyrosine Kinase Inhibitor 57 Prognostic Factors 57 Ranolazine 57 Treatment Naive Patients 57 FOLPI 57 Anticoagulant 57 REYATAZ ® 57 Corticosteroid 57 flutamide 57 APTIVUS r 57 FIRMAGON 57 Percutaneous Coronary Intervention 57 Relapsing Remitting Multiple Sclerosis 57 Glycemic Control 57 Anti Tumor 57 Bare Metal Stent 57 Renal Anemia 57 Advanced Colorectal Cancer 57 Unresectable 57 Drug Regimen 57 Trastuzumab 57 Decitabine 57 8mg/kg 57 duplex ultrasonography 57 Immunosuppression 57 ARIXTRA R 57 Improved Survival 57 Cognitive Function 57 Pulmonary Arterial Hypertension 57 adalimumab Humira 57 Study Evaluating 57 Advanced Ovarian Cancer 57 weekly intravenous infusions 57 Cognitive Impairment 57 Chronic Myeloid Leukemia 57 Commonly Used 57 Acute Ischemic Stroke 57 CRp 57 Patients Treated 57 Advanced Melanoma 57 Proves Effective 57 Shows Promise Against 56 Who Underwent 56 Phase IIa Clinical Trial 56 Chronic Heart Failure 56 Generalized Anxiety Disorder 56 CCyR 56 Recurrent Glioblastoma 56 Unfractionated Heparin 56 Capecitabine 56 Disease Modifying 56 Fungal Infections 56 biologic DMARD 56 DOXIL 56 Tyrosine Kinase Inhibitors 56 Melphalan 56 Minimally Invasive Treatment 56 Phase 2b Trial 56 #mg QD [002] 56 Improve Outcomes 56 HPV Vaccine Gardasil 56 Radiofrequency Ablation 56 Therapy Improves 56 Corneal Transplant 56 Bone Metastases 56 Paliperidone ER 56 Phase III Trials 56 Diabetic Kidney Disease 56 Test Detects 56 Clostridium difficile Infection 56 Anti TNF 56 concomitant medications 56 Osteoporosis Treatment 56 Tiotropium 56 Invasive Fungal Infections 56 Clinical Outcomes 56 Skeletal Muscle 56 dosing cohorts 56 Phase IIb Trial 56 Liver Metastases 56 Evaluable 56 Potent Antiviral Activity 56 TAXOTERE R 56 Fibromyalgia Pain 56 Antitumor 56 Community Acquired Pneumonia 56 Breast Cancer Treatment 56 Study Shows Benefits 56 Anthracycline 56 Anticoagulants 56 Autologous Stem Cell Transplantation 56 Advanced Pancreatic Cancer 56 Iron Deficiency Anemia 56 Left Atrial 56 Radiofrequency Ablation RFA 56 Lung Injury 56 Bloodstream Infections 56 Mitomycin C 56 Cyclophosphamide 56 Rheumatoid 56 Boosts Survival 56 eosinophilic asthma 56 visceral metastases 56 Carotid Endarterectomy 56 Uterine Fibroids 56 remission CR 56 Tumor Growth 56 Chronic Constipation 56 pyrazinamide 56 Pemetrexed 56 Meets Primary Endpoint 56 INFERGEN 56 Skin Lesions 56 paclitaxel Taxol R 56 Combination Therapy 56 huN# DM1 56 Hospitalized Patients 56 Better Outcomes 56 Previously Untreated 56 doxorubicin cyclophosphamide 56 Beta Blockers 56 Treatment Resistant 56 alefacept 56 Phase 2a Trial 56 Subtypes 56 Versus Placebo 56 Colorectal Adenomas 56 Relapsed Refractory 56 PegIFN RBV 56 Infliximab 56 Single Dose 56 Aortic Stenosis 56 Clinical Evaluation 56 Retreatment 56 Bosentan 56 Accelerated Approval 56 Receptor Antagonists 56 dosing intervals 56 Diabetic Neuropathic Pain 56 Coronary Arteries 56 cis retinoic acid 56 Juvenile Idiopathic Arthritis 56 Neuroendocrine Tumors 56 CLINICAL PHARMACOLOGY 55 Demonstrates Efficacy 55 Treating Depression 55 Therapeutic Intervention 55 riociguat 55 Antidepressant Treatment 55 CLARITY study 55 Investigational Compound 55 Total Hip Arthroplasty 55 Viral Suppression 55 #mg q8h 55 HSCT 55 BEXXAR therapeutic regimen 55 postexposure prophylaxis 55 Adjuvant Treatment 55 Newly Diagnosed Breast Cancer 55 Opioid Addiction 55 anagrelide 55 mu opioid agonist analgesics 55 lanthanum carbonate 55 recurrent glioblastoma multiforme 55 Prophylactic Treatment 55 Drug Combo 55 undergoing Percutaneous Coronary 55 Short Stature 55 CHMP Opinion 55 Peginterferon 55 Fluorouracil 55 Heart Failure Patients 55 Seasonal Flu Vaccine 55 Sustained Efficacy 55 Node Positive 55 PPSV# 55 Risk Stratification 55 #mg BID [003] 55 concurrent ITP 55 Metabolic Disorder 55 Treatment Approaches 55 paclitaxel cisplatin 55 mild hepatic impairment 55 Cervical Dystonia 55 Remission 55 Neoadjuvant Chemotherapy 55 Gestational Diabetes 55 Oral Calcitonin 55 Ischemic Stroke 55 4mg/kg 55 Genes Linked 55 Statin Therapy 55 Bipolar Depression 55 symptomatic hyponatremia 55 Pregnancy Linked 55 Newly Diagnosed 55 ribavirin therapy 55 TYGACIL 55 Dry Powder Inhalers 55 Extended Release 55 Chronic Pelvic Pain 55 Demonstrates Positive 55 Fewer Side Effects 55 Antibiotic Use 55 Rilonacept 55 Recurrent Prostate Cancer 55 Stem Cell Transplants 55 #mg BID [001] 55 Prostate Cancer Patients 55 Screening Tool 55 Induction Therapy 55 Predict Response 55 abiraterone acetate 55 Inhaled Liposomal Ciprofloxacin 55 Cardiovascular Outcomes 55 Patients Suffering 55 dose escalation phase 55 Genital Herpes 55 Traficet EN 55 Enoxaparin 55 Paroxysmal Atrial Fibrillation 55 Rotavirus Vaccine 55 Chronic Sinusitis 55 OvaRex MAb 55 Teva Provides Update 55 Chronic Insomnia 55 ALT flares 55 Carboplatin Paclitaxel 55 interferon ribavirin 55 Hematological Cancers 55 #mg/m# [002] 55 Bulimia Nervosa 55 Liver Injury 55 Home Hemodialysis 55 severe neutropenia 55 Reduce Mortality 55 APTIVUS 55 Reduced Risk 55 Natalizumab 55 Drug Shows Promise 55 polyarticular 55 Relieve Depression 55 Contraindications 55 Antibiotic Treatment 55 Phase III Clinical Trial 55 Radical Prostatectomy 55 MGd 55 IFN α 55 Levels Linked 55 neurologic progression 55 NOMID 55 Neonates 55 Bronchial Thermoplasty 55 Blood Pressure Reduction 55 allogeneic transplantation 55 Smoking Linked 55 moderate renal impairment 55 certolizumab 55 Antidepressants Linked 55 HBeAg + 55 HERCEPTIN 55 Phase Ib Clinical Trial 55 metastatic malignant 54 Efficacious 54 ACE Inhibitors 54 Data Suggest 54 RoACTEMRA 54 Systemic Lupus Erythematosus SLE 54 Showed Significant 54 briakinumab 54 Epilepsy Drug 54 allogeneic hematopoietic stem cell 54 Less Invasive 54 ROTARIX 54 Guidelines Issued 54 Postmenopausal Women 54 MAGE A3 ASCI 54 Shingles Vaccine 54 Drug Candidate 54 HER2 Positive Breast Cancer 54 Inhaled Corticosteroids 54 GnRH agonists 54 Prolongs Life 54 Refractory Hodgkin Lymphoma 54 ara C 54 external beam radiotherapy 54 hematologic abnormalities 54 status epilepticus 54 Inflammatory Pain 54 Etravirine 54 Intravesical 54 Atomoxetine 54 Stem Cell Treatment 54 Bosutinib 54 Differential Diagnosis 54 EMEND 54 underwent resection 54 galiximab 54 chemoradiation therapy 54 Interferon Alfa 54 Long Term Survival 54 Mouse Model 54 MEK Inhibitor 54 LYSTEDA 54 Placebo Controlled Study 54 AGILECT R 54 Bezielle 54 Raptiva r 54 Low Dose 54 Significantly Reduced 54 receiving golimumab 54 Induction Chemotherapy 54 Seasonal Influenza Vaccine 54 Double Blind Randomized 54 rtPA 54 6 mercaptopurine 54 weekly subcutaneous injections 54 GnRH agonist 54 G CSFs 54 Fixed Dose 54 Reduces Pain 54 Targeted Therapy 54 Aortic Valve Replacement 54 tipranavir r 54 Renal Artery 54 Anticoagulation 54 Endovascular Treatment 54 Sleep Disturbances 54 #mg/day [002] 54 Controlled Study 54 anakinra 54 Aortic Valve 54 Allogeneic Stem 54 pretransplant 54 Cardiovascular Disease Risk 54 Prostate Biopsy 54 Emerging Therapies 54 Surgical Procedures 54 mg kg dose 54 erlotinib Tarceva ® 54 Blinatumomab 54 Mental Illnesses 54 Liver Failure 54 Pancreatic Adenocarcinoma 54 trastuzumab Herceptin ® 54 Chronic Hepatitis B 54 CHOP chemotherapy 54 Mitral Regurgitation 54 Protein Linked 54 Tonsillectomy 54 COPEGUS R 54 Urinary Incontinence 54 Sustained Reduction 54 Cocaine Addiction 54 Electrical Stimulation 54 Treatment Outcomes 54 Laryngeal Cancer 54 relapsing remitting MS RRMS 54 Lubiprostone 54 Intra Arterial 54 corticosteroid therapy 54 Investigator Initiated 54 IND Application 54 Respiratory Distress 54 Prevent Stroke 54 Rectal Cancer 54 Bevacizumab 54 Posaconazole 54 Oral Cavity 54 Watchful Waiting 54 Dupuytren Contracture 54 Lung Cancer Survival 54 hepatic insufficiency 54 Learning Experiences 54 ribavirin RBV 54 Kinoid 54 evaluable subjects 54 cidofovir 54 Suicidal Behavior 54 Postmenopausal 54 Pregnancy Outcomes 54 remissions 54 Heart Ailments 54 Colorectal Screening 54 Catheter Ablation 54 Diuretic 54 Risedronate 54 Coronary Artery Bypass Surgery 54 Migraine Headache 54 Coronary Artery Bypass Graft 54 IRESSA 54 Hepatitis B Vaccine 54 Disruptive Behavior 54 Dialysis Patients 54 Acne Drug 54 Renal Cancer 54 Vidaza azacitidine 54 biochemical relapse 54 Antiangiogenic 54 paliperidone palmitate 54 Uterine Cancer 54 papillary renal cell carcinoma 54 torsade de pointes 54 Prolonged Exposure 54 Enlarged Prostate 54 Psychiatric Disorders 54 cefotaxime 54 BENICAR HCT 54 Study Shows Promise 54 Diamyd r 54 See WARNINGS 54 Therapeutic Efficacy 54 Cell Transplants 54 Treatment Outcome 54 canakinumab 53 Treatment Shows Promise 53 Aurora Kinase 53 Chronic Lymphocytic Leukemia 53 Poster Presentations 53 Chronic Lung 53 eculizumab therapy 53 REVLIMID ® 53 Vaccine Candidate 53 Bronchodilator 53 Psychotic Disorders 53 Treating Heart Failure 53 Clinical Trial Results 53 Adjunctive Treatment 53 adjuvant tamoxifen 53 chronic eosinophilic leukemia 53 ZYVOX 53 clodronate 53 #mg ATC 53 MYCAMINE 53 standard chemotherapy regimen 53 Antiviral Agents 53 Estrogen Therapy 53 tolterodine 53 inhaled bronchodilators 53 Oral Mucositis 53 Gentle Path compound 53 Drug Prevents 53 Kidney Function 53 Intervention Trial 53 CHAMPION PCI 53 rFSH 53 Lung Cancer Patients 53 Renal Transplantation 53 Immunotherapeutic 53 severe exacerbations 53 Parenteral Nutrition 53 Intrathecal 53 Renal Cell Carcinoma 53 partial remissions 53 Chronic Kidney 53 Obese Patients 53 Mesothelioma Treatment 53 Total Knee Arthroplasty 53 serologically active systemic lupus 53 Sexually Dangerous 53 MIRCERA 53 asymptomatic hyperuricemia 53 Pafuramidine 53 Therapy Shows Promise 53 neutropenic patients 53 FDA Approves Drug 53 Inhaled Steroids 53 Acute Heart Failure 53 Symptom Relief 53 Study Showed 53 Retinal Vein Occlusion 53 Chelation Therapy 53 Lung Cancer Trial 53 NICE Recommends 53 mesalamine granules 53 Antiretrovirals 53 Periodontal Disease 53 Antiviral Drugs 53 Diagnostic Tests 53 Lowers Risk 53 Acute Stroke 53 Paraplatin ® 53 low dose cytarabine 53 First Patient Dosed 53 Intensity Modulated 53 Naive Patients 53 Integrase Inhibitor 53 serologic testing 53 anthracyclines taxanes 53 RECIST Response Evaluation Criteria 53 antimuscarinic 53 Cytotoxic 53 Hypertensive adverse reactions 53 pyridostigmine 53 inhaled budesonide 53 Certolizumab 53 Preterm Labor 53 Heel Pain 53 E1 INT TM 53 Intracerebral Hemorrhage 53 Alemtuzumab 53 Therapy Reduces 53 Peripheral Vascular Disease 53 azacitidine 53 Metastatic Breast Cancer 53 Suicidality 53 Pediatric Asthma 53 intracranial hemorrhage ICH 53 golimumab CNTO 53 Randomized Study 53 Antidepressant Drug 53 Thyroid Hormone 53 Ischemic 53 bortezomib refractory 53 VELCADE melphalan 53 Effectively Treats 53 Replacement Therapy 53 FDA APPROVES 53 Muscle Wasting 53 abatacept 53 Recurrent Breast Cancer 53 Cladribine tablets 53 Cellular Immunotherapy 53 AZT zidovudine Retrovir 53 Reduces Risk 53 Non inferiority 53 concomitant antibiotics 53 Immunosuppressant 53 CERVARIX 53 Screening Mammography 53 Anthrax Vaccine 53 Occlusion 53 Introgen ADVEXIN 53 Lymphoma Patients 53 Breast Cancer Recurrence 53 ß blockers 53 cisplatin chemotherapy 53 Radiation Induced 53 nab paclitaxel 53 lymph node dissection 53 Pain Medication 53 Nonsurgical 53 Current Controlled Trials 53 Platinol ® cisplatin 53 paclitaxel eluting stents 53 Gene Linked 53 Surgical Treatment 53 Anticancer Drug 53 Antipsychotic Drugs 53 Fixed Dose Combination 53 Asthma Symptoms 53 FDA Warns Against 53 antiarrhythmic medications 53 FOLFOX6 53 Treatment 53 Doxil ® 53 Lower Extremity 53 EXJADE 53 Osteoporosis Drugs 53 REMICADE ® 53 Migraine Treatment 53 histologically confirmed 53 Psychiatric Illness 53 JAK2 V#F 53 HPV Vaccination 52 virological response 52 Dementia Diagnosis 52 pegylated liposomal doxorubicin 52 Kidney Transplant Recipients 52 adalimumab etanercept 52 opioid dependent 52 T1DM 52 Tumor Targeting 52 Highly Active Antiretroviral 52 Hepatitis C Treatment 52 Malignancies 52 telaprevir dosed 52 Abciximab 52 alteplase 52 ritonavir boosted protease inhibitor 52 Often Misdiagnosed 52 tocilizumab 52 Anticonvulsant 52 IN PATIENTS WITH 52 REVLIMID R 52 mg/m2 dose 52 chemotherapy docetaxel 52 colorectal carcinomas 52 Bone Fracture 52 Lowers Blood Pressure 52 Orthostatic Hypotension 52 Rifampin 52 QTc intervals 52 cytogenetic response 52 Embolization 52 folinic acid 52 Lung Function 52 dual endothelin receptor antagonist 52 Prostate Cancer Treatment 52 adjuvant endocrine therapy 52 Fecal Incontinence 52 Valvular Heart Disease 52 Brain Stimulation 52 Gout Patients 52 oral FTY# 52 D Sequenced Treatment 52 Hepatitis B Virus 52 Multicenter Automatic Defibrillator Implantation 52 Myelodysplastic Syndrome MDS 52 tumor regressions 52 Cognitive Dysfunction 52 Efficacy Trial 52 TORISEL 52 Lung Tumors 52 Improve Diagnosis 52 Acute Myeloid Leukaemia AML 52 NATRECOR ® 52 pouchitis 52 Transdermal Delivery 52 Immunologic 52 PSMA ADC 52 Bone Marrow Transplants 52 Vaginal Gel 52 debulking surgery 52 CIMZIA TM 52 poor metabolizers 52 Thrombotic 52 haematologic 52 Hemorrhagic Stroke 52 Peginterferon alfa 2b 52 MabCampath 52 Renal Failure 52 Bisphosphonate 52 Eye Exams 52 PTLD 52 HBeAg negative 52 Immunized 52 APTIVUS ritonavir 52 Treatment Options 52 Spinal Manipulation 52 postoperative chemotherapy 52 Eculizumab 52 antiepileptics 52 Post Operative 52 antiandrogen 52 Gout Drug 52 Abatacept 52 Diet Supplement 52 CLL SLL 52 Abdominal Pain 52 antithymocyte globulin 52 Susceptibility Testing 52 antiretroviral naïve 52 rheumatoid arthritis osteoarthritis ankylosing 52 Genes Predict 52 #:#-#,# CrossRef Medline [002] 52 protease inhibitor PI 52 flavopiridol 52 Genital Warts 52 Detection Evaluation 52 Lupus Drug 52 Genes Identified 52 Angioedema 52 Healthbeat Report 52 SJIA 52 Peripheral Arterial 52 chronic GVHD 52 Breast Tumor 52 nadolol 52 DMSA 52 Human Neural Stem 52 tipranavir 52 Premature Infants 52 Prostatectomy 52 Immune Mediated 52 oral prednisolone 52 Mantoux test 52 dose titration 52 Extracorporeal Shock Wave 52 Mitoxantrone 52 MRSA Infections 52 Breast Density 52 Aptivus ® 52 REYATAZ ritonavir 52 Adjuvant therapy 52 interferon alfa 2b 52 Loxapine 52 imipenem 52 Blood Thinning 52 octreotide LAR 52 Regimen 52 endoscopic remission 52 co trimoxazole 52 carboplatin paclitaxel 52 Chronic Wounds 52 abacavir Ziagen 52 Cancer Recurrence 52 Urinary Tract Infections 52 Bioequivalence 52 Muscle Function 52 Etiology 52 plus methotrexate 52 Slow Progression 52 Febrile Neutropenia 52 CYP #D# 52 Breast conserving 52 HER2 Positive 52 Mantle Cell Lymphoma 52 Lymphocytic 52 Gastric Bypass Surgery 52 relapsing multiple sclerosis 52 Gastric Cancer 52 Weight Reduction 52 untreated multiple myeloma 52 Therapy HAART 52 Arikace 52 ACTEMRA TM 52 Protease inhibitor 52 Organ Rejection 52 Valopicitabine 52 Hematological 52 FDA Okays 52 anthracycline therapy 52 WBPA 52 Demonstrates Potential 52 continuous intravenous infusion 52 immunological responses 52 rapid virologic response 52 Exacerbation 52 LHRH agonist 52 Drug Resistant 52 viral kinetics 52 Potentially Fatal 52 antithrombotic therapy 52 Multiple Ascending Dose 52 nilotinib 52 Prostate Cancer Vaccine 52 Endovascular Repair 52 Dalbavancin 52 Treatable 52 androgen suppression 52 achieved ACR# 52 Slows Progression 52 Oral Fluid 51 Gum Disease 51 cyclophosphamide methotrexate 51 Squamous Cell Carcinoma 51 Antibody Tests 51 Advanced Gastric Cancer 51 Node Negative 51 autoantibody positive 51 Periodic Screening Diagnosis 51 Postherpetic Neuralgia 51 Brain Metastases 51 Acute Migraine 51 Torisel 51 Antifungal 51 Helps Smokers Quit 51 randomized #:#:# 51 hypoglycaemic episodes 51 Aneurysm Repair 51 aripiprazole 51 metastatic kidney 51 Endometrial Cancer 51 Artery Disease 51 #mg dose [001] 51 Cystectomy 51 Therapeutic Vaccine 51 LHRH agonists 51 FUSILEV enhances 51 pancreatic resection 51 undetectable HBV DNA 51 leukemia AML 51 Prescription Medication 51 decitabine 51 Non Invasive Treatment 51 Response Evaluation Criteria 51 virologic responses 51 endothelin receptor antagonists 51 NCT# ClinicalTrials.gov 51 Posttraumatic Stress 51 Sleep Disturbance 51 Zoledronic acid 51 Acne Rosacea 51 SPRIX ® 51 Obesity Linked 51 Relieve Pain 51 ipsilateral stroke 51 ribavirin Copegus ® 51 fibrinolysis 51 Edurant 51 sublingual tablets 51 LHRH receptor positive 51 Acute Renal Failure 51 antiandrogens 51 GARDASIL ® 51 doxorubicin docetaxel 51 Vertebroplasty 51 Cardiac Stem Cell 51 Cisplatin 51 Oral Insulin 51 percutaneous transluminal coronary angioplasty 51 Female Sexual Arousal 51 Leukocyte 51 Lymphoid 51 Whooping Cough Vaccine 51 HBeAg seroconversion 51 Covered Stent 51 Gastrointestinal Tract 51 Herbal Supplements 51 superficial bladder cancer 51 Eszopiclone 51 Exacerbations 51 Could Prevent 51 Inflammatory Arthritis 51 Inflammatory Response 51 Helicobacter pylori eradication 51 pelvic lymphadenectomy 51 Treatment EPSDT 51 Pegasys ® 51 BALF 51 Cognitive Behavioral Therapy 51 adverse cytogenetics 51 Immune Tolerance 51 thrombocytosis 51 Psoriasis Drug 51 achieved sustained virological 51 Student Loan Repayment 51 paclitaxel poliglumex 51 Myelodysplastic Syndrome 51 patients evaluable 51 Atrial Flutter 51 Clinically Proven 51 Spinal Fusion 51 hematological parameters 51 CMV infection 51 Meningococcal vaccine 51 Symptom Improvement 51 anthracycline containing